Impact of Adherence Education and Monitoring on Community Pharmacy Star Ratings and Patient Satisfaction

Adherence, Patient Clinical Trial

Official title:

Impact of Adherence Education and Monitoring on Community Pharmacy Star Ratings and Patient Satisfaction

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03848884
• Other study ID #: HM20014333
• Status: Completed
• Phase: N/A
• Start date: March 1, 2019
• Est. completion date: October 16, 2019

Study information

• Verified date: October 2019
• Source: Virginia Commonwealth University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Does monthly adherence monitoring and education by a pharmacy resident impact Kroger star ratings, compared to the current standard?

Description:

To evaluate if a monthly adherence monitoring and education service impacts the percent of patients adherent to oral diabetes and renin-angiotensin system antagonists (RASA) medications based on star ratings. It will also evaluate patient satisfaction of the adherence monitoring and education service, using a standard questionnaire.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 34
• Est. completion date: October 16, 2019
• Est. primary completion date: October 16, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. 18 years or older

2. Patients pre-identified by Kroger analytics in ClinicalQ - Patients with PDC < 80%

3. Patient taking oral diabetes medications and/or RASA medications (ACE-I, ARB, direct renin inhibitor)

Exclusion Criteria:

1. Patients who are enrolled in MedSync or Autorefill program

2. Patients who are lost to follow-up

3. Incomplete/missing documentation of an encounter

4. Prisoners, children

Related Conditions & MeSH terms

• Adherence, Patient

Intervention

Behavioral:
• Adherence monitoring and education
Standardized medication counseling and education combined with individual patient customized guidance and counseling - administered monthly.

Locations

Country	Name	City	State
United States	Virginia Commonwealth University	Richmond	Virginia

Sponsors (1)

Lead Sponsor	Collaborator
Virginia Commonwealth University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Satisfaction with education and monitoring service	"Patient Satisfaction Survey" includes an 8-item 5-point likert scale (Strongly Disagree, Disagree, Neutral, Agree, Strongly Agree) about whether or not the pharmacist provided adequate education to the patient, whether or not the patient feels his/her health benefited from the service, and if the patient would recommend the service. The "Patient Satisfaction Survey" will be analyzed using descriptive statistics to determine how satisfied patients were with the medication adherence monitoring and education service.	6 months
Primary	Adherence in oral diabetes medications determined by star ratings	Determine change in patients who are adherent to oral diabetes medications, determined by pharmacy star ratings in adherence measures; pharmacy analytics determines the star rating measure (on a scale of 1 to 5 stars, with 5 being the highest) before and after the study. A student t-test will be used to determine if there is a difference.	Baseline to 6 months
Primary	Adherence in renin-angiotensin system antagonists (RASA) medications determined by star ratings	Determine change in patients who are adherent to RASA medications, determined by pharmacy star ratings in adherence measures; pharmacy analytics determines the star rating measure (on a scale of 1 to 5 stars, with 5 being the highest) before and after the study. A student t-test will be used to determine if there is a difference.	Baseline to 6 months
Secondary	Change in proportion of days covered (PDC)	Determine change in PDC after monthly follow-up on medication adherence and education; pharmacy analytics determines patient PDC in normal practice. The mean PDC for each patient at the end of the six-month study period will be compared to the baseline using a student t-test.	Baseline to 6 months